Table S8 from Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Table S8 shows cell viability IC50 values in Ba/F3 engineered RAS cell lines.
Fields of Study & Subjects
Protein Kinase Regulation and GTPase Signaling
Protein Tyrosine Phosphatases
Melanoma and MAPK Pathways
Publication details
- Publication date
- 16 March 2026
- Language
- EN